English

PERNIX THERAPEUTICS HOLDINGS, INC.

EDGAR

Quarterly report (10-Q) · filed 2018-11-13

105 filing records in this dataset, filed from 1997-03-31 to 2018-11-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

28.1 million USD

2018 Q1 · USD

Exact inputs and evidence

Revenue: 28139000 USD Source

Operating margin

-32.22%

2018 Q1 · %

Exact inputs and evidence

Operating Income: -9066000 USD Source
Revenue: 28139000 USD Source

Operating cash flow

-267 thousand USD

2018 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -267000 USD Source

Free cash flow

-271 thousand USD

2018 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -267000 USD Source
Capital Expenditure: 4000 USD Source

Cash and cash equivalents: 24.5 million USD 2018-09-30 Source
Exact value

24511000 USD
Long-term debt including current maturities: 322 million USD 2018-09-30 Source
Exact value

322457000 USD
Shares outstanding: 14 million shares 2018-09-30 Source
Exact value

13957733 shares

Reported share-count change

21.03% · 2.43 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

11532423 shares · 2017-09-30· Source
13957733 shares · 2018-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

144 million USD

2017-04-01 – 2018-03-31

Exact inputs and evidence

Revenue: 34316000 USD · 2017-04-01 – 2017-06-30 Source
Revenue: 40469000 USD · 2017-07-01 – 2017-09-30 Source
Revenue: 41541000 USD · 2017-10-01 – 2017-12-31 Source
Revenue: 28139000 USD · 2018-01-01 – 2018-03-31 Source

Net income

-76.4 million USD

2017-10-01 – 2018-09-30

Exact inputs and evidence

Net income: -32423000 USD · 2017-10-01 – 2017-12-31 Source
Net income: -18584000 USD · 2018-01-01 – 2018-03-31 Source
Net income: -13513000 USD · 2018-04-01 – 2018-06-30 Source
Net income: -11845000 USD · 2018-07-01 – 2018-09-30 Source

Operating cash flow

-22.1 million USD

2017-10-01 – 2018-09-30

Exact inputs and evidence

Operating cash flow: -5939000 USD · 2017-01-01 – 2017-12-31 Source
Operating cash flow: -9218000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: -267000 USD · 2018-01-01 – 2018-03-31 Source
Operating cash flow: -8076000 USD · 2018-01-01 – 2018-06-30 Source
Operating cash flow: -267000 USD · 2018-01-01 – 2018-03-31 Source
Operating cash flow: -25395000 USD · 2018-01-01 – 2018-09-30 Source
Operating cash flow: -8076000 USD · 2018-01-01 – 2018-06-30 Source

Capital expenditure

152 thousand USD

2017-10-01 – 2018-09-30

Exact inputs and evidence

Capital expenditure: 18000 USD · 2017-01-01 – 2017-12-31 Source
Capital expenditure: 5000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 4000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 98000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 4000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 139000 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 98000 USD · 2018-01-01 – 2018-06-30 Source

Free cash flow

-22.3 million USD

2017-10-01 – 2018-09-30

Exact inputs and evidence

Operating cash flow: -5939000 USD · 2017-01-01 – 2017-12-31 Source
Operating cash flow: -9218000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: -267000 USD · 2018-01-01 – 2018-03-31 Source
Operating cash flow: -8076000 USD · 2018-01-01 – 2018-06-30 Source
Operating cash flow: -267000 USD · 2018-01-01 – 2018-03-31 Source
Operating cash flow: -25395000 USD · 2018-01-01 – 2018-09-30 Source
Operating cash flow: -8076000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 18000 USD · 2017-01-01 – 2017-12-31 Source
Capital expenditure: 5000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 4000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 98000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 4000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 139000 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 98000 USD · 2018-01-01 – 2018-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2018-11-13.

Financial data available through: 2017-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2017-12-31
Operating income: 10 of 11 periods available· newest 2017-12-31
Net income: 10 of 11 periods available· newest 2017-12-31
Operating cash flow: 9 of 11 periods available· newest 2017-12-31
Capital expenditure: 8 of 11 periods available· newest 2017-12-31
Total assets: 10 of 11 periods available· newest 2017-12-31
Total liabilities: 10 of 11 periods available· newest 2017-12-31
Current assets: 10 of 11 periods available· newest 2017-12-31
Current liabilities: 10 of 11 periods available· newest 2017-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2017-12-31
Long-term debt including current maturities: 6 of 11 periods available· newest 2017-12-31
Shares outstanding: 8 of 11 periods available· newest 2017-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+3.7%

Prior period

USD 140.86 million

2016-01-01 – 2016-12-31
Current period

USD 146.07 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

146068000 − 140856000 = 5212000 USD

140856000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
146068000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PERNIX THERAPEUTICS HOLDINGS, INC. · 2017-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Year-over-year change in Revenue: 5212000 USD Concept: fundies:Revenue Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 146068000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#234438 Filing: 000113626118000075 Input fundies:Revenue: 140856000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#234557 Filing: 000113626118000075
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 92.45 million

Prior period

−USD 169.59 million

2016-01-01 – 2016-12-31
Current period

−USD 77.14 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

-77141000 − -169590000 = 92449000 USD

-169590000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
-77141000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2017-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Year-over-year change in Net income: 92449000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -77141000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000308/ptx-20180930.xml#108326 Filing: 000113626118000308 Input fundies:NetIncome: -169590000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#237279 Filing: 000113626118000075
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 10.56 million

Prior period

−USD 16.5 million

2016-01-01 – 2016-12-31
Current period

−USD 5.94 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

-5939000 − -16501000 = 10562000 USD

-16501000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
-5939000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2017-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Year-over-year change in Operating cash flow: 10562000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -5939000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#323091 Filing: 000113626118000075 Input fundies:OperatingCashFlow: -16501000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#323277 Filing: 000113626118000075
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-98.2%

Prior period

USD 984,000

2016-01-01 – 2016-12-31
Current period

USD 18,000

2017-01-01 – 2017-12-31

Exact inputs and evidence

18000 − 984000 = -966000 USD

984000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
18000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PERNIX THERAPEUTICS HOLDINGS, INC. · 2017-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Year-over-year change in Capital expenditure: -966000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 18000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#328490 Filing: 000113626118000075 Input fundies:CapitalExpenditure: 984000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#328673 Filing: 000113626118000075
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2017 2017-01-01 – 2017-12-31

Revenue USD 146.07 million 100% of revenue
Cost of revenue USD 44.63 million 31% of revenue
Operating expenses USD 77.59 million 53% of revenue
Other operating costs Derived USD 80.31 million 55% of revenue
Operating income −USD 56.46 million −39% of revenue
Tax, interest and other Derived USD 20.68 million 14% of revenue
Net income −USD 77.14 million −53% of revenue

Cash

Operating cash flow −USD 5.94 million −4.1% of revenue
Capital expenditure USD 18,000 0% of revenue
Free cash flow Derived −USD 5.96 million −4.1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Not shown: operating income or net income is not reported.
2009 Net income was higher than operating income, so the split is not drawn.
2010 28%71%
2011 14%78%
2012 Operating loss: operating costs were 103% of revenue.
2013 Operating loss: operating costs were 163% of revenue.
2014 Operating loss: operating costs were 125% of revenue.
2015 Operating loss: operating costs were 158% of revenue.
2016 Operating loss: operating costs were 200% of revenue.
2017 Operating loss: operating costs were 139% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	0	1643965 Derived	-1643965	-1106114 Derived	-537851	Unavailable	Source 2008-01-01 – 2008-12-31: 0 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -1643965 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -537851 USD Inspect Net Income Open source
2009 2009-01-01 – 2009-12-31	27930352	18714025 Derived	9216327	-23377 Derived	9239704	Unavailable	Source 2009-01-01 – 2009-12-31: 27930352 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 9216327 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 9239704 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 9943072 USD Inspect Operating Cash Flow Open source
2010 2010-01-01 – 2010-12-31	33227433	23607088 Derived	9620345	311558 Derived	9308787	4547034 Derived	Source 2010-01-01 – 2010-12-31: 33227433 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 9620345 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 9308787 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 4666614 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 119580 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	60607000	47499021 Derived	13107979	4760378 Derived	8347601	9221846 Derived	Source 2011-01-01 – 2011-12-31: 60607000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 13107979 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 8347601 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: 9397442 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 175596 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	61313000	63002000 Derived	-1689000	-279000 Derived	-1410000	-2252000 Derived	Source 2012-01-01 – 2012-12-31: 61313000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -1689000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -1410000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -1926000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 326000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	84872000	138728000 Derived	-53856000	-28221000 Derived	-25635000	-7059000 Derived	Source 2013-01-01 – 2013-12-31: 84872000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -53856000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -25635000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -6531000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 528000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	121747000	151961000 Derived	-30214000	5072000 Derived	-35286000	7719000 Derived	Source 2014-01-01 – 2014-12-31: 121747000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -30214000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -35286000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 8896000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 1177000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	175850000	277104000 Derived	-101254000	47061000 Derived	-148315000	-15961000 Derived	Source 2015-01-01 – 2015-12-31: 175850000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -101254000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -148315000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -14749000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 1212000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	140856000	281184000 Derived	-140328000	29262000 Derived	-169590000	-17485000 Derived	Source 2016-01-01 – 2016-12-31: 140856000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -140328000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -169590000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -16501000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 984000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	146068000	202527000 Derived	-56459000	20682000 Derived	-77141000	-5957000 Derived	Source 2017-01-01 – 2017-12-31: 146068000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -56459000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -77141000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -5939000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 18000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 146.1M 2017

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	0	Revenue: 0 Open source
20092009-12-31	Revenue	27930352	Revenue: 27930352 Open source
20102010-12-31	Revenue	33227433	Revenue: 33227433 Open source
20112011-12-31	Revenue	60607000	Revenue: 60607000 Open source
20122012-12-31	Revenue	61313000	Revenue: 61313000 Open source
20132013-12-31	Revenue	84872000	Revenue: 84872000 Open source
20142014-12-31	Revenue	121747000	Revenue: 121747000 Open source
20152015-12-31	Revenue	175850000	Revenue: 175850000 Open source
20162016-12-31	Revenue	140856000	Revenue: 140856000 Open source
20172017-12-31	Revenue	146068000	Revenue: 146068000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

3.7% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 27930352 Open source Revenue: 0 Open source
20102010-12-31	Year over year	19%	Revenue: 33227433 Open source Revenue: 27930352 Open source
20112011-12-31	Year over year	82.4%	Revenue: 60607000 Open source Revenue: 33227433 Open source
20122012-12-31	Year over year	1.2%	Revenue: 61313000 Open source Revenue: 60607000 Open source
20132013-12-31	Year over year	38.4%	Revenue: 84872000 Open source Revenue: 61313000 Open source
20142014-12-31	Year over year	43.4%	Revenue: 121747000 Open source Revenue: 84872000 Open source
20152015-12-31	Year over year	44.4%	Revenue: 175850000 Open source Revenue: 121747000 Open source
20162016-12-31	Year over year	-19.9%	Revenue: 140856000 Open source Revenue: 175850000 Open source
20172017-12-31	Year over year	3.7%	Revenue: 146068000 Open source Revenue: 140856000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -38.7% 2017

Net margin -52.8% 2017

Free cash flow margin -4.1% 2017

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	Not reported	Operating Income: -1643965 Open source Revenue: 0 Open source
20092009-12-31	Operating margin	33%	Operating Income: 9216327 Open source Revenue: 27930352 Open source
20102010-12-31	Operating margin	29%	Operating Income: 9620345 Open source Revenue: 33227433 Open source
20112011-12-31	Operating margin	21.6%	Operating Income: 13107979 Open source Revenue: 60607000 Open source
20122012-12-31	Operating margin	-2.8%	Operating Income: -1689000 Open source Revenue: 61313000 Open source
20132013-12-31	Operating margin	-63.5%	Operating Income: -53856000 Open source Revenue: 84872000 Open source
20142014-12-31	Operating margin	-24.8%	Operating Income: -30214000 Open source Revenue: 121747000 Open source
20152015-12-31	Operating margin	-57.6%	Operating Income: -101254000 Open source Revenue: 175850000 Open source
20162016-12-31	Operating margin	-99.6%	Operating Income: -140328000 Open source Revenue: 140856000 Open source
20172017-12-31	Operating margin	-38.7%	Operating Income: -56459000 Open source Revenue: 146068000 Open source
20082008-12-31	Net margin	Not reported	Net Income: -537851 Open source Revenue: 0 Open source
20092009-12-31	Net margin	33.1%	Net Income: 9239704 Open source Revenue: 27930352 Open source
20102010-12-31	Net margin	28%	Net Income: 9308787 Open source Revenue: 33227433 Open source
20112011-12-31	Net margin	13.8%	Net Income: 8347601 Open source Revenue: 60607000 Open source
20122012-12-31	Net margin	-2.3%	Net Income: -1410000 Open source Revenue: 61313000 Open source
20132013-12-31	Net margin	-30.2%	Net Income: -25635000 Open source Revenue: 84872000 Open source
20142014-12-31	Net margin	-29%	Net Income: -35286000 Open source Revenue: 121747000 Open source
20152015-12-31	Net margin	-84.3%	Net Income: -148315000 Open source Revenue: 175850000 Open source
20162016-12-31	Net margin	-120.4%	Net Income: -169590000 Open source Revenue: 140856000 Open source
20172017-12-31	Net margin	-52.8%	Net Income: -77141000 Open source Revenue: 146068000 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 27930352 Open source Operating Cash Flow: 9943072 Open source
20102010-12-31	Free cash flow margin	13.7%	Revenue: 33227433 Open source Operating Cash Flow: 4666614 Open source Capital Expenditure: 119580 Open source
20112011-12-31	Free cash flow margin	15.2%	Revenue: 60607000 Open source Operating Cash Flow: 9397442 Open source Capital Expenditure: 175596 Open source
20122012-12-31	Free cash flow margin	-3.7%	Revenue: 61313000 Open source Operating Cash Flow: -1926000 Open source Capital Expenditure: 326000 Open source
20132013-12-31	Free cash flow margin	-8.3%	Revenue: 84872000 Open source Operating Cash Flow: -6531000 Open source Capital Expenditure: 528000 Open source
20142014-12-31	Free cash flow margin	6.3%	Revenue: 121747000 Open source Operating Cash Flow: 8896000 Open source Capital Expenditure: 1177000 Open source
20152015-12-31	Free cash flow margin	-9.1%	Revenue: 175850000 Open source Operating Cash Flow: -14749000 Open source Capital Expenditure: 1212000 Open source
20162016-12-31	Free cash flow margin	-12.4%	Revenue: 140856000 Open source Operating Cash Flow: -16501000 Open source Capital Expenditure: 984000 Open source
20172017-12-31	Free cash flow margin	-4.1%	Revenue: 146068000 Open source Operating Cash Flow: -5939000 Open source Capital Expenditure: 18000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -5.9M 2017

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	Not reported	No source recorded
20092009-12-31	Operating cash flow	9943072	Operating Cash Flow: 9943072 Open source
20102010-12-31	Operating cash flow	4666614	Operating Cash Flow: 4666614 Open source
20112011-12-31	Operating cash flow	9397442	Operating Cash Flow: 9397442 Open source
20122012-12-31	Operating cash flow	-1926000	Operating Cash Flow: -1926000 Open source
20132013-12-31	Operating cash flow	-6531000	Operating Cash Flow: -6531000 Open source
20142014-12-31	Operating cash flow	8896000	Operating Cash Flow: 8896000 Open source
20152015-12-31	Operating cash flow	-14749000	Operating Cash Flow: -14749000 Open source
20162016-12-31	Operating cash flow	-16501000	Operating Cash Flow: -16501000 Open source
20172017-12-31	Operating cash flow	-5939000	Operating Cash Flow: -5939000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6M 2017

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	Unavailable	No source recorded
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: 9943072 Open source
20102010-12-31	Free cash flow	4547034	Operating Cash Flow: 4666614 Open source Capital Expenditure: 119580 Open source
20112011-12-31	Free cash flow	9221846	Operating Cash Flow: 9397442 Open source Capital Expenditure: 175596 Open source
20122012-12-31	Free cash flow	-2252000	Operating Cash Flow: -1926000 Open source Capital Expenditure: 326000 Open source
20132013-12-31	Free cash flow	-7059000	Operating Cash Flow: -6531000 Open source Capital Expenditure: 528000 Open source
20142014-12-31	Free cash flow	7719000	Operating Cash Flow: 8896000 Open source Capital Expenditure: 1177000 Open source
20152015-12-31	Free cash flow	-15961000	Operating Cash Flow: -14749000 Open source Capital Expenditure: 1212000 Open source
20162016-12-31	Free cash flow	-17485000	Operating Cash Flow: -16501000 Open source Capital Expenditure: 984000 Open source
20172017-12-31	Free cash flow	-5957000	Operating Cash Flow: -5939000 Open source Capital Expenditure: 18000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

185.4% 2017

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Liabilities / assets	40.7%	Total Liabilities: 5594961 Open source Total Assets: 13750145 Open source
20092009-12-31	Liabilities / assets	59.9%	Total Liabilities: 8036440 Open source Total Assets: 13412648 Open source
20102010-12-31	Liabilities / assets	58.9%	Total Liabilities: 27128593 Open source Total Assets: 46033532 Open source
20112011-12-31	Liabilities / assets	39.9%	Total Liabilities: 32940292 Open source Total Assets: 82563971 Open source
20122012-12-31	Liabilities / assets	55.1%	Total Liabilities: 138597841 Open source Total Assets: 251446687 Open source
20132013-12-31	Liabilities / assets	47.6%	Total Liabilities: 100663000 Open source Total Assets: 211386000 Open source
20142014-12-31	Liabilities / assets	82.5%	Total Liabilities: 394432000 Open source Total Assets: 478024000 Open source
20152015-12-31	Liabilities / assets	93.4%	Total Liabilities: 466094000 Open source Total Assets: 499191000 Open source
20162016-12-31	Liabilities / assets	136.7%	Total Liabilities: 424504000 Open source Total Assets: 310441000 Open source
20172017-12-31	Liabilities / assets	185.4%	Total Liabilities: 378262000 Open source Total Assets: 204005000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.98× 2017

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	1.79×	Current Assets: 8563184 Open source Current Liabilities: 4789528 Open source
20092009-12-31	Current assets / current liabilities	1.43×	Current Assets: 11480522 Open source Current Liabilities: 8036440 Open source
20102010-12-31	Current assets / current liabilities	1.67×	Current Assets: 32090001 Open source Current Liabilities: 19253593 Open source
20112011-12-31	Current assets / current liabilities	2.16×	Current Assets: 68109905 Open source Current Liabilities: 31480292 Open source
20122012-12-31	Current assets / current liabilities	1.77×	Current Assets: 95715341 Open source Current Liabilities: 53947267 Open source
20132013-12-31	Current assets / current liabilities	1.1×	Current Assets: 76385000 Open source Current Liabilities: 69468000 Open source
20142014-12-31	Current assets / current liabilities	1.23×	Current Assets: 119868000 Open source Current Liabilities: 97677000 Open source
20152015-12-31	Current assets / current liabilities	1.18×	Current Assets: 155690000 Open source Current Liabilities: 132443000 Open source
20162016-12-31	Current assets / current liabilities	0.99×	Current Assets: 108910000 Open source Current Liabilities: 109528000 Open source
20172017-12-31	Current assets / current liabilities	0.98×	Current Assets: 92284000 Open source Current Liabilities: 93801000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	−USD 537,851 Exact value Exact value: -537851 USD 2008-01-01 – 2008-12-31: -537851 USD Inspect Net Income Open source Share or cite Citation for Net Income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2008-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Net Income: -537851 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -537851 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/0001354488-10-000553.txt#6792 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	USD 9.24 million Exact value Exact value: 9239704 USD 2009-01-01 – 2009-12-31: 9239704 USD Inspect Net Income Open source Share or cite Citation for Net Income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2009-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Net Income: 9239704 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9239704 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/0001354488-11-001006.txt#10007 The citation records this snapshot. The page link may show a newer release later.	USD 9.94 million Exact value Exact value: 9943072 USD 2009-01-01 – 2009-12-31: 9943072 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2009-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Operating Cash Flow: 9943072 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9943072 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/0001354488-11-001006.txt#11879 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	USD 9.31 million Exact value Exact value: 9308787 USD 2010-01-01 – 2010-12-31: 9308787 USD Inspect Net Income Open source Share or cite Citation for Net Income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2010-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Net Income: 9308787 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9308787 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448812001488/ptx-20111231.xml#37678 Filing: 000135448812001488 The citation records this snapshot. The page link may show a newer release later.	USD 4.67 million Exact value Exact value: 4666614 USD 2010-01-01 – 2010-12-31: 4666614 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2010-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Operating Cash Flow: 4666614 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4666614 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448812001488/ptx-20111231.xml#44937 Filing: 000135448812001488 The citation records this snapshot. The page link may show a newer release later.	USD 119,580 Exact value Exact value: 119580 USD 2010-01-01 – 2010-12-31: 119580 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PERNIX THERAPEUTICS HOLDINGS, INC. · 2010-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Capital Expenditure: 119580 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 119580 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448812001488/ptx-20111231.xml#48044 Filing: 000135448812001488 The citation records this snapshot. The page link may show a newer release later.	USD 4.55 million Calculation and evidence 4666614 − 119580 USD Exact free cash flow: 4547034 USD 2010-01-01 – 2010-12-31: 4666614 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 119580 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2010-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Free cash flow: 4547034 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4666614 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448812001488/ptx-20111231.xml#44937 Filing: 000135448812001488 Input fundies:CapitalExpenditure: 119580 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448812001488/ptx-20111231.xml#48044 Filing: 000135448812001488 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	USD 8.35 million Exact value Exact value: 8347601 USD 2011-01-01 – 2011-12-31: 8347601 USD Inspect Net Income Open source Share or cite Citation for Net Income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2011-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Net Income: 8347601 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 8347601 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448814001218/ptx-20131231.xml#100356 Filing: 000135448814001218 The citation records this snapshot. The page link may show a newer release later.	USD 9.4 million Exact value Exact value: 9397442 USD 2011-01-01 – 2011-12-31: 9397442 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2011-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Operating Cash Flow: 9397442 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9397442 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448814001218/ptx-20131231.xml#122295 Filing: 000135448814001218 The citation records this snapshot. The page link may show a newer release later.	USD 175,596 Exact value Exact value: 175596 USD 2011-01-01 – 2011-12-31: 175596 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PERNIX THERAPEUTICS HOLDINGS, INC. · 2011-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Capital Expenditure: 175596 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 175596 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448814001218/ptx-20131231.xml#127053 Filing: 000135448814001218 The citation records this snapshot. The page link may show a newer release later.	USD 9.22 million Calculation and evidence 9397442 − 175596 USD Exact free cash flow: 9221846 USD 2011-01-01 – 2011-12-31: 9397442 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 175596 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2011-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Free cash flow: 9221846 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9397442 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448814001218/ptx-20131231.xml#122295 Filing: 000135448814001218 Input fundies:CapitalExpenditure: 175596 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448814001218/ptx-20131231.xml#127053 Filing: 000135448814001218 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 1.41 million Exact value Exact value: -1410000 USD 2012-01-01 – 2012-12-31: -1410000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2012-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Net Income: -1410000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1410000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448815000878/ptx-20141231.xml#107386 Filing: 000135448815000878 The citation records this snapshot. The page link may show a newer release later.	−USD 1.93 million Exact value Exact value: -1926000 USD 2012-01-01 – 2012-12-31: -1926000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2012-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Operating Cash Flow: -1926000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1926000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448815000878/ptx-20141231.xml#1693121 Filing: 000135448815000878 The citation records this snapshot. The page link may show a newer release later.	USD 326,000 Exact value Exact value: 326000 USD 2012-01-01 – 2012-12-31: 326000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PERNIX THERAPEUTICS HOLDINGS, INC. · 2012-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Capital Expenditure: 326000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 326000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448815000878/ptx-20141231.xml#1696920 Filing: 000135448815000878 The citation records this snapshot. The page link may show a newer release later.	−USD 2.25 million Calculation and evidence -1926000 − 326000 USD Exact free cash flow: -2252000 USD 2012-01-01 – 2012-12-31: -1926000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 326000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2012-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Free cash flow: -2252000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1926000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448815000878/ptx-20141231.xml#1693121 Filing: 000135448815000878 Input fundies:CapitalExpenditure: 326000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000135448815000878/ptx-20141231.xml#1696920 Filing: 000135448815000878 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 25.64 million Exact value Exact value: -25635000 USD 2013-01-01 – 2013-12-31: -25635000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2013-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Net Income: -25635000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25635000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626116000419/ptx-20151231.xml#329490 Filing: 000113626116000419 The citation records this snapshot. The page link may show a newer release later.	−USD 6.53 million Exact value Exact value: -6531000 USD 2013-01-01 – 2013-12-31: -6531000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2013-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Operating Cash Flow: -6531000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6531000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626116000419/ptx-20151231.xml#514497 Filing: 000113626116000419 The citation records this snapshot. The page link may show a newer release later.	USD 528,000 Exact value Exact value: 528000 USD 2013-01-01 – 2013-12-31: 528000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PERNIX THERAPEUTICS HOLDINGS, INC. · 2013-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Capital Expenditure: 528000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 528000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626116000419/ptx-20151231.xml#525733 Filing: 000113626116000419 The citation records this snapshot. The page link may show a newer release later.	−USD 7.06 million Calculation and evidence -6531000 − 528000 USD Exact free cash flow: -7059000 USD 2013-01-01 – 2013-12-31: -6531000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 528000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2013-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Free cash flow: -7059000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6531000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626116000419/ptx-20151231.xml#514497 Filing: 000113626116000419 Input fundies:CapitalExpenditure: 528000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626116000419/ptx-20151231.xml#525733 Filing: 000113626116000419 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 35.29 million Exact value Exact value: -35286000 USD 2014-01-01 – 2014-12-31: -35286000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2014-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Net Income: -35286000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35286000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626116000419/ptx-20151231.xml#329103 Filing: 000113626116000419 The citation records this snapshot. The page link may show a newer release later.	USD 8.9 million Exact value Exact value: 8896000 USD 2014-01-01 – 2014-12-31: 8896000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2014-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Operating Cash Flow: 8896000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8896000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626116000419/ptx-20151231.xml#514312 Filing: 000113626116000419 The citation records this snapshot. The page link may show a newer release later.	USD 1.18 million Exact value Exact value: 1177000 USD 2014-01-01 – 2014-12-31: 1177000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PERNIX THERAPEUTICS HOLDINGS, INC. · 2014-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Capital Expenditure: 1177000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1177000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626116000419/ptx-20151231.xml#525548 Filing: 000113626116000419 The citation records this snapshot. The page link may show a newer release later.	USD 7.72 million Calculation and evidence 8896000 − 1177000 USD Exact free cash flow: 7719000 USD 2014-01-01 – 2014-12-31: 8896000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 1177000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2014-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Free cash flow: 7719000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8896000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626116000419/ptx-20151231.xml#514312 Filing: 000113626116000419 Input fundies:CapitalExpenditure: 1177000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626116000419/ptx-20151231.xml#525548 Filing: 000113626116000419 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 148.32 million Exact value Exact value: -148315000 USD 2015-01-01 – 2015-12-31: -148315000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2015-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Net Income: -148315000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -148315000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626117000069/ptx-20161231.xml#277609 Filing: 000113626117000069 The citation records this snapshot. The page link may show a newer release later.	−USD 14.75 million Exact value Exact value: -14749000 USD 2015-01-01 – 2015-12-31: -14749000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2015-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Operating Cash Flow: -14749000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14749000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626117000069/ptx-20161231.xml#391585 Filing: 000113626117000069 The citation records this snapshot. The page link may show a newer release later.	USD 1.21 million Exact value Exact value: 1212000 USD 2015-01-01 – 2015-12-31: 1212000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PERNIX THERAPEUTICS HOLDINGS, INC. · 2015-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Capital Expenditure: 1212000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1212000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626117000069/ptx-20161231.xml#397339 Filing: 000113626117000069 The citation records this snapshot. The page link may show a newer release later.	−USD 15.96 million Calculation and evidence -14749000 − 1212000 USD Exact free cash flow: -15961000 USD 2015-01-01 – 2015-12-31: -14749000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 1212000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2015-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Free cash flow: -15961000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14749000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626117000069/ptx-20161231.xml#391585 Filing: 000113626117000069 Input fundies:CapitalExpenditure: 1212000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626117000069/ptx-20161231.xml#397339 Filing: 000113626117000069 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 169.59 million Exact value Exact value: -169590000 USD 2016-01-01 – 2016-12-31: -169590000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2016-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Net Income: -169590000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -169590000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#237279 Filing: 000113626118000075 The citation records this snapshot. The page link may show a newer release later.	−USD 16.5 million Exact value Exact value: -16501000 USD 2016-01-01 – 2016-12-31: -16501000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2016-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Operating Cash Flow: -16501000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16501000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#323277 Filing: 000113626118000075 The citation records this snapshot. The page link may show a newer release later.	USD 984,000 Exact value Exact value: 984000 USD 2016-01-01 – 2016-12-31: 984000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PERNIX THERAPEUTICS HOLDINGS, INC. · 2016-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Capital Expenditure: 984000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 984000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#328673 Filing: 000113626118000075 The citation records this snapshot. The page link may show a newer release later.	−USD 17.49 million Calculation and evidence -16501000 − 984000 USD Exact free cash flow: -17485000 USD 2016-01-01 – 2016-12-31: -16501000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 984000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2016-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Free cash flow: -17485000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16501000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#323277 Filing: 000113626118000075 Input fundies:CapitalExpenditure: 984000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#328673 Filing: 000113626118000075 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 77.14 million Exact value Exact value: -77141000 USD 2017-01-01 – 2017-12-31: -77141000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PERNIX THERAPEUTICS HOLDINGS, INC. · 2017-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Net Income: -77141000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -77141000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000308/ptx-20180930.xml#108326 Filing: 000113626118000308 The citation records this snapshot. The page link may show a newer release later.	−USD 5.94 million Exact value Exact value: -5939000 USD 2017-01-01 – 2017-12-31: -5939000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2017-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Operating Cash Flow: -5939000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5939000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#323091 Filing: 000113626118000075 The citation records this snapshot. The page link may show a newer release later.	USD 18,000 Exact value Exact value: 18000 USD 2017-01-01 – 2017-12-31: 18000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PERNIX THERAPEUTICS HOLDINGS, INC. · 2017-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Capital Expenditure: 18000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#328490 Filing: 000113626118000075 The citation records this snapshot. The page link may show a newer release later.	−USD 5.96 million Calculation and evidence -5939000 − 18000 USD Exact free cash flow: -5957000 USD 2017-01-01 – 2017-12-31: -5939000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 18000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PERNIX THERAPEUTICS HOLDINGS, INC. · 2017-12-31 PERNIX THERAPEUTICS HOLDINGS, INC. (edgar:1024126) Free cash flow: -5957000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1024126?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5939000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#323091 Filing: 000113626118000075 Input fundies:CapitalExpenditure: 18000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1024126/000113626118000075/ptx-20171231.xml#328490 Filing: 000113626118000075 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

105 filings · 2,685 latest values · 2,685 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001024126, 1024126, edgar:1024126

Also known as GOLF TRUST OF AMERICA INC, PERNIX THERAPEUTICS HOLDINGS, INC., Pernix Therapeutics Holdings, Inc.

PERNIX THERAPEUTICS HOLDINGS, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2017 2017-01-01 – 2017-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation